Early detection of oral potentially malignant disorders (OPMDs) and oral squamous cell carcinoma (OSCC) can improve patient outcomes. Although biopsy remains the diagnostic standard, this multi-part series developed in collaboration with the Center for Integrative Global Oral Health at the University of Pennsylvania School of Dental Medicine (Penn Dental Medicine) provides updated recommendations on the appropriate use of cytology, vital staining, light-based and salivary adjuncts.
For questions or comments about the living guideline, please contact guidelineprogram@ada.org.
Please note: the infographic below may take a moment to load.